Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Human Papillomavirus: Vaccination

Department of Health and Social Care written question – answered on 12th March 2020.

Alert me about debates like this

Photo of Crispin Blunt Crispin Blunt Conservative, Reigate

To ask the Secretary of State for Health and Social Care, what steps Public Health England plans to take to assess the effectiveness of the HPV vaccination programme.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Public Health England (PHE) is conducting surveillance activities to monitor the effectiveness of the National Human Papillomavirus (HPV) Vaccination Programme. The current HPV vaccine protects against two high-risk HPV types, HPV16 and HPV18 which cause around 80% of cervical cancers in the United Kingdom and two low-risk HPV types, HPV6 and HPV11 which cause most genital warts.

Surveillance conducted among young sexually active women in England has compared changes in the number of women who have a HPV infection over time since the introduction of the HPV vaccination.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.